Nephrology: As It Was Then, But Is Not Now

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Recent Advances in Traditional Chinese Medicine for Kidney Disease

Copyright © 2015 by the American Osteopathic Association.

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Uric Acid and Long-term Outcomes in CKD

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Frederik Persson, Peter Rossing Kidney International Supplements

American Journal of Kidney Diseases

Evaluation of Kidney Donors: Core Curriculum 2018

Uric Acid as a Target of Therapy in CKD

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Changing Terminology in Renal Research: The Impact of Consensus

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,

A Decade After the KDOQI CKD Guidelines

Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD

Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey Varun Agrawal, MD, Amit K.

What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes? Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Looking at the Urine: The Renaissance of an Unbroken Tradition

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

National Kidney Foundation American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Utility and Validity of Estimated GFR–Based Surrogate Time-to-Event End Points in CKD: A Simulation Study Tom Greene, PhD, Chia-Chen Teng, MS, Lesley.

Karl D. Nolph, MD, American Journal of Kidney Diseases

Lifetime Incidence of CKD Stages 3-5 in the United States

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials Hiddo J. Lambers Heerspink, PhD, Hocine.

Julie A. Wright Nunes, MD, MPH, Kerri L

Polyunsaturated Fatty Acids and Kidney Disease

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Quiz Page April 2008 American Journal of Kidney Diseases

Evidence and Outcomes in CKD

Within-Person Variability in Kidney Measures

Drug Dose Adjustments in Patients With Renal Impairment

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Methods for guideline development

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Making Music American Journal of Kidney Diseases

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Patient Safety Issues in CKD: Core Curriculum 2015

Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

What Should a Guideline Panel Do When Evidence Is Inconclusive

Presentation transcript:

Nephrology: As It Was Then, But Is Not Now Garabed Eknoyan, MD American Journal of Kidney Diseases Volume 69, Issue 1, Pages 129-135 (January 2017) DOI: 10.1053/j.ajkd.2016.06.029 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Key members of the Work Group that developed the first Kidney Disease Outcomes Quality Initiative (KDOQI) clinical practice guideline, evaluation, classification, and stratification of chronic kidney disease.29 Standing from left to right are Andrew S. Levey, MD, Chair of the Work Group; Cynda Ann Johnson, MD, MBA, member of the Work Group; Garabed Eknoyan, MD, co-chair of KDOQI; and Josef Coresh, MD, PhD, Vice-Chair of the Work Group. Courtesy of KDOQI. American Journal of Kidney Diseases 2017 69, 129-135DOI: (10.1053/j.ajkd.2016.06.029) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 The annual number of published articles from 1965 to 2014 listed in PubMed for the acronyms CKD (chronic kidney disease; solid black columns) and eGFR (estimated glomerular filtration rate; open grey columns). American Journal of Kidney Diseases 2017 69, 129-135DOI: (10.1053/j.ajkd.2016.06.029) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions